23 April 2015 : Original article
Prognostic Factors of Lymphoma Patients after Autologous Stem Cell Transplantation
Fenghua QianCE, Wenxia FanBD, Xia WeiBD, Yan ZhuBD, Gang FuBD, Dabing QinBD, Xiaobo TianBD, Li PeiBD, Shuangnian XuBD, Jieping ChenAF, Yong ZhangAFDOI: 10.12659/AOT.892975
Ann Transplant 2015; 20:225-232
Abstract
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is considered to be a cure for lymphoma. However, factors related to its prognosis remain unclear.
MATERIAL AND METHODS: Eighty patients diagnosed with lymphoma and treated with autologous HSCT (Auto HSCT) were recruited. The primary endpoints included overall survival (OS) and progression-free survival (PFS).
RESULTS: After a median follow-up of 37.9 months, the 3-year OS was 75%. Univariate analysis showed age (P=0.020), elevated lactate dehydrogenase (LDH) (P=0.031), international prognostic index (IPI) (P=0.015), Eastern Cooperative Oncology Group (ECOG) (P=0.048), bone marrow involvement (P=0.038), and time to neutrophil recovery (P=0.043) were prognostic factors of lymphoma. Multivariate analysis revealed IPI (hazard ratio [HR] 1.60, 95% confidence interval [CI] 1.09–2.34, P=0.016) and time to neutrophil recovery (HR 2.69, 95% CI 1.02–7.07, P=0.045) were independent factors correlated with OS.
CONCLUSIONS: IPI and neutrophil recovery are recommendatory predictors for lymphoma patients after Auto HSCT.
In Press
Original article
Learning Curve and Outcomes of Pure Laparoscopic Donor Major Hepatectomy Performed by Fellowship-Trained Su...Ann Transplant In Press; DOI: 10.12659/AOT.953061
Original article
Role of Psychological Resilience on Emotional Health in Kidney and Liver Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952824
Original article
Analysis of Factors Influencing the Psychological State of Patients After Autologous Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.953645
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Most Viewed Current Articles
24 Aug 2021 : Review article 21,725
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 17,946
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,696
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,590
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604